Adam Lloyd

Author PubWeight™ 14.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. Value Health 2013 1.77
2 Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists. Appl Health Econ Health Policy 2014 1.51
3 The current and future burden and cost of overactive bladder in five European countries. Eur Urol 2006 1.06
4 Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press 2002 1.03
5 The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine. Vaccine 2003 1.01
6 Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK. J Med Econ 2011 0.89
7 Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD. Respir Med 2011 0.89
8 ER:YAG laser for 3-dimensional debridement of canal systems: use of photon-induced photoacoustic streaming. Dent Today 2012 0.87
9 Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective. Curr Med Res Opin 2010 0.84
10 Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications. Int J Technol Assess Health Care 2004 0.82
11 Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US. J Med Econ 2012 0.81
12 The 'Healthy Dads, Healthy Kids' community effectiveness trial: study protocol of a community-based healthy lifestyle program for fathers and their children. BMC Public Health 2011 0.81
13 Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States. J Med Econ 2012 0.79
14 Electroglottographic analysis of actresses and nonactresses' voices in different levels of intensity. J Voice 2013 0.76
15 An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study. Curr Med Res Opin 2004 0.76
16 Laryngoscopic, acoustic, perceptual, and functional assessment of voice in rock singers. Folia Phoniatr Logop 2014 0.75
17 Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study. Acta Haematol 2006 0.75
18 An economic evaluation of the costs and benefits of heparin rationalisation in a hospital pharmacy. Pharm World Sci 2004 0.75
19 Intracerebral hemorrhage following multiple bee stings. JAAPA 2013 0.75